XREF LIMITED — Interim / Quarterly Report 2018

Oct 30, 2017

Appendix 4C

==> picture [147 x 34] intentionally omitted <==

Quarterly report for entities subject to Listing Rule 4.7B

Name of entity Xref Limited

Xref Limited
ACN 122 404 666 Consolidated statement of cash flows	Quarter ended ("current quarter")
	30 September 17
1 Cash flows from operating activities 1.1 Receipts from customers 1.2 Payments for (a) research and development (b) product manufacturing and operating costs (c) advertising and marketing (d) leased assets (e) staff costs (f) administration and corporate costs 1.3 Dividends received 1.4 Interest received 1.5 Interest and other costs of finance paid 1.6 Income taxes paid 1.7 Government grants and tax incentives 1.8 Other (provide details if material) - GST on sales for the period - Net foreign exchange gain 1.9 Net cash from / (used in) operating activities	Current quarter $A'000 1,334 (86) (227) (609) (313) (2,707) (763) - 33 - - - 142 32	Year to date (12 months) $A'000 1,334 (86) (227) (609) (313) (2,707) (763) - 33 - - - 142 32 3 months
	(3,165)	(3,165)
2 Cash flows from investing activities 2.1 Payments to acquire (a) property, plant and equipment (b) businesses (item 10) (c) investments (d) intellectual property (e) other non-current assets 2.2 Proceeds from disposal of: (a) property, plant and equipment (b) businesses (item 10) (c) investments (d) intellectual property (e) other non-current assets 2.3 Cash flows from loans to other entities 2.4 Dividends received (see note 3) 2.5 Other (provide details if material) - 2.6 Net cash from / (used in) investing activities	(42) - - - - - - - - - - - -	(42) - - - - - - - - - - - -
	(42)	(42)

Xref Limited

Page 1 of 3

Appendix 4C - 30 September 2017

3 3.1 3.2 3.3 Proceeds from exercise of share options 3.4 3.5 Proceeds from borrowings 3.6 Repayment of borrowings 3.7 3.8 Dividends paid 3.9 Other (provide details if material) 3.10 Net cash from / (used in) financing activities Cash flows from financing activities Proceeds from issues of shares Proceeds from issue of convertible notes Transaction costs related to issues of shares, convertible notes or options Transaction costs related to loans and borrowings	Current quarter $A'000 7,500 - - (484) - - - -	Year to date (12 months) $A'000 7,500 - - (484) - - - -
	7,016	7,016
4 4.1 4.2 4.3 4.4 4.5 Effect of movement in exchange rates on cash held 4.6 Cash and cash equivalents at end of quarter Net increase (decrease) in cash and cash equivalents for the period held Cash and cash equivalents at beginning of quarter /year to date Net cash from / (used in) operating activities (item 1.9 above) Net cash from / (used in) investing activities (item 2.6 above) Net cash from / (used in) financing activities (item 3.10 above)	Current quarter $A'000 4,111 (3,165) (42) 7,016 10	Year to date (12 months) $A'000 4,111 (3,165) (42) 7,016 10
	7,930	7,930
5 Reconciliation of cash and cash equivalents 5.1 Bank balances 5.2 Call deposits 5.3 Bank overdrafts 5.4 Other (provide details) 5.5 Cash and cash equivalents at end of quarter at the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts	Current quarter $A'000 7,859 71 - -	Previous quarter $A'000 4,040 71 - -
	7,930	4,111
6 6.1 6.2 Payments to directors of the entity and associates of the directors Aggregate amount of payments to these parties included in item 1.2 Aggregate amount of cash flow from loans to these parties included in item 2.3	Current quarter $A'000 310 (1)
	Current quarter $A'000 310 (1)
6.3 Include below any explanation necessary to understand the transactions included in items 6.1 and 6.2

Xref Limited

Page 2 of 3

Appendix 4C - 30 September 2017

7 7.1 7.2 7.3 Payments to related entities of the entity and associates of the related entities Include below any explanation necessary to understand the transactions included in 7.1 and 7.2 Aggregate amount of cash flow from loans to these parties included in item 2.3 Aggregate amount of payments to these parties included in item 1.2	Current quarter $A'000 - 182

==> picture [460 x 97] intentionally omitted <==

----- Start of picture text -----

8 Financing facilities available
Add notes as necessary for an understanding of Total facility
the position. amount at Amount drawn at
quarter end quarter end
$A'000 $A'000
8.1 Loan facilities - -
8.2 Credit standby arrangements - -
8.3 Other (please specify) - -
----- End of picture text -----

• 8.4 Include below a description of each facility above, including the lender, interest rate and whether it is secured or unsecured. If any additional facilities have been entered into or are proposed to be entered into after quarter end, include details of those facilities as well.

• 9 Estimated cash outflows for next quarter $A'000 9.1 Research and Development 45 9.2 Product manufacturing and operating costs 75 9.3 Advertising and marketing 445 9.4 Leased assets 245 9.5 Staff costs 2150 9.6 Administration and corporate costs 250 9.7 Other (provide details if material) 9.8 Total estimated cash outflows 3,210 10 Acquisitions and disposals of business Acquisitions Disposals 10.1 n/a n/a

• 10.1 Name of entity

• 10.2 Place of incorporation or registration

• 10.3 Consideration for acquisition or disposal

• 10.4 Total net assets 10.5 Nature of business

Compliance statement

• 1 This statement has been prepared in accordance with accounting standards and policies which comply with Listing Rule 19.11A.

• 2 This statement does give a true and fair view of the matters disclosed.

Sign here:

==> picture [99 x 47] intentionally omitted <==

Print name: James Solomons, CFO

Date: 31 October 2017

Xref Limited

Page 3 of 3

Appendix 4C - 30 September 2017